-
Alzheimers, cut, drugs, dysfunction, erectile, men, News, risk, Science, study, suggests, Tech, Viagra
Viagra and erectile dysfunction drugs could cut Alzheimer’s risk in men, study suggests | Science & Tech News
admin
Erectile dysfunction drugs such as Viagra could be inadvertently cutting the chances of men developing Alzheimer’s disease, research suggests. Alzheimer’s Research UK called the findings “encouraging,” saying the chance of repurposing drugs to tackle the condition could help “accelerate progress and open up new avenues to prevent or treat dementia-causing diseases”. However the charity said…
-
Alzheimers, decadesold, developed, disease, doctors, find, medical, News, patients, Science, Tech, treatment
Five Alzheimer’s patients developed disease from decades-old medical treatment, doctors find | Science & Tech News
admin
Five people in the UK are believed to have developed Alzheimer’s Disease as a result of medical treatment decades earlier, doctors have revealed. The world-first research suggests the individuals acquired a rogue protein that causes the form of dementia from growth hormone taken from the brains of deceased people. The doctors say Alzheimer’s itself is…
-
accurate, Alzheimers, blood, disease, lumbar, News, painful, puncture, Science, study, suggests, Tech, test
Blood test for Alzheimer’s disease could be as accurate as painful lumbar puncture, study suggests | Science & Tech News
admin
A blood test could be just as good at detecting the signs of Alzheimer’s disease as painful and invasive lumbar punctures, research suggests. Measuring levels of a protein called p-tau217 in the blood could be just as accurate at detecting signs of the progressive condition, experts say. The protein is a marker for biological changes…
-
Alzheimer’s diagnosis blood tests could be offered on NHS within five years, experts say | Science & Tech News
admin
Blood tests which help detect Alzheimer’s could be made available on the NHS within five years as charities join forces for a £5m project. Diagnosing the condition is often difficult and relies on drawing a sample of spinal fluid from the lower back – a process known as a lumbar puncture – or brain imaging.…
-
Alzheimer’s: First drug to slow progression of disease gains approval of US regulator the FDA | Science & Tech News
admin
The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzheimer’s disease for the first time. The FDA has granted full regulatory approval to Leqembi – a drug by Japanese manufacturers Eisai and US drugmakers Biogen. Up to now, other approved drugs targeted only the symptoms of the…
-
New drug can reduce Alzheimer’s disease symptoms by up to 35% | Science & Tech News
admin
A second drug has shown the ability to slow the progression of the leading form of dementia. Results of a study, released in a preliminary form by drug maker Eli Lilly, show their drug donanemab reduced the rate of cognitive decline of Alzheimer’s patients in a trial by between 27 and 35%. Those on the…
-
HRT could prevent Alzheimer’s disease in at-risk women, study suggests | Science & Tech News
admin
Hormone replacement therapy (HRT) could help prevent Alzheimer’s disease in women at risk of developing the condition, a study suggests. Researchers from East Anglia and Edinburgh universities said HRT, which helps control symptoms of the menopause, is associated with better memory, cognitive function and larger brain volume in later life in women carrying a gene…
-
What is Alzheimer’s disease, how common is it – and will new drug lecanemab help patients in the UK? | UK News
admin
A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer’s disease. After an 18-month trial of 1,800 patients, lecanemab slowed patients’ mental decline by 27%. Although scientists are hailing a “new era” in treatment, strains on the NHS and the scale and complexity of the…
-
New drug brings hope that decades-long slog to find Alzheimer’s cure might pay off | Science & Tech News
admin
Science is a slog. Not a series of “Eureka!” moments. It’s why I hate the word “breakthrough” when it comes to research discoveries. But in the case of this new drug for Alzheimer’s that word is more than justified. Not because lecanemab is a cure for the disease that is destroying the lives of hundreds…
-
Alzheimers, cure, day, decline, dementia, doctors, drug, fuelling, hope, Lecanemab, memory, News, Science, slows, Tech
Lecanemab: New Alzheimer’s drug slows decline in memory – fuelling hope doctors will one day cure dementia | Science & Tech News
admin
Doctors have hailed a “new era” of medicine after a study showed for the first time that a drug can slow the debilitating symptoms of Alzheimer’s. Results from the clinical trial also revealed that the drug lecanemab cleared clumps of a protein called amyloid – thought to be a key cause of the most common…